Piramal Pharma has announced a rights issue for investors. The subscription window opened on August 8, 2023. It will remain open until August 17, 2023. You can subscribe to Piramal Pharma’s rights issue if you have the company’s stocks in your portfolio. Let us see the details associated with the rights issue and how you …


